NARI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Inari Medical Inc

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.
CEO
Employees
456
Headquarters

News

Berenberg Starts Inari Medical Inc. at Buy
Sep 29, 2022 10:34am

https://www.investing.com/news/pro/berenberg-starts-inari-medical-inc-at-buy-432SI-2901775


Source:Investing.com
Inari Medical Inc. (NASDAQ: NARI) Stock Forecast For 2022: Increases Growth Prospects To $9 Per Share
Sep 28, 2022 14:30pm

In the last trading session, 1.34 million Inari Medical Inc. (NASDAQ:NARI) shares changed hands as the company’s beta touched 0. With the company’s per share price at $69.25 changed hands at $0.5 or 0.73% during last session, the market valuation stood at $3.61B. NARI’s last price was a discount, traded about -44.4% off its 52-week … Inari Medical Inc. (NASDAQ: NARI) Stock Forecast For 2022: Increases Growth Prospects To $9 Per Share Read More »


Source:Marketing Sentinel
Analyst Predictions On Inari Medical Inc.’s (NASDAQ: NARI) Future Growth
Sep 27, 2022 14:30pm

Inari Medical Inc. (NASDAQ:NARI) price closed higher on Monday, September 26, jumping 2.49% above its previous close. A look at the daily price movement shows that the last close reads $67.08, with intraday deals fluctuated between $66.98 and $69.93. The company’s 5Y monthly beta was ticking 1.45. Taking into account the 52-week price action we … Analyst Predictions On Inari Medical Inc.’s (NASDAQ: NARI) Future Growth Read More »


Source:Stocks Register
Investing in Inari Medical Inc. (NARI) might be an excellent idea, but the stock is currently overvalued/undervalued
Sep 27, 2022 14:24pm

Inari Medical Inc. (NASDAQ:NARI) closed Monday at $68.75 per share, up from $67.08 a day earlier. While Inari Medical Inc. has overperformed by 2.49%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -17.53%, with highs and lows ranging from $100.00 to $50.50, whereas […]


Source:US Post News
Study assessing Inari Medical''s blood clot removal system shows low rate of adverse events
Sep 19, 2022 18:29pm

Inari Medical (NARI) said a study assessing real-world outcomes for 800 patients in the U.S. who were treated with the company''s FlowTriever system showed a low rate of major adverse events


Source:Seeking Alpha
Inari Medical (NARI) Investor Presentation - Slideshow (NASDAQ:NARI)
Sep 15, 2022 17:27pm

The following slide deck was published by Inari Medical, Inc.


Source:Seeking Alpha
Inari initiated Hold at Truist; notes competition overshadows market growth (NASDAQ:NARI)
Sep 13, 2022 16:56pm

Inari Medical (NARI), a health equipment company focused on venous diseases, traded lower in the afternoon hours Tuesday as Truist launched its coverage with a Hold recommendation…


Source:Seeking Alpha
Inari Medical Stock: Growth Set To Reaccelerate In Back Half
Sep 07, 2022 22:37pm

Shares of Inari are down 25% year to date and Covid limited its ability to develop the DVT market. Click here to read the full analysis of NARI stock.


Source:Seeking Alpha
Inari Medical Inc. (NASDAQ: NARI) Could Soar To Much Higher Prices In Coming Months
Sep 07, 2022 13:30pm

In the last trading session, 1.19 million Inari Medical Inc. (NASDAQ:NARI) shares changed hands as the company’s beta touched 0. With the company’s per share price at $69.06 changed hands at $2.31 or 3.46% during last session, the market valuation stood at $3.75B. NARI’s last price was a discount, traded about -44.8% off its 52-week … Inari Medical Inc. (NASDAQ: NARI) Could Soar To Much Higher Prices In Coming Months Read More »


Source:Marketing Sentinel
Do investors need to be concerned about Inari Medical Inc. (NARI)?
Sep 07, 2022 12:32pm

In Tuesday’s session, Inari Medical Inc. (NASDAQ:NARI) marked $69.06 per share, up from $66.75 in the previous session. While Inari Medical Inc. has overperformed by 3.46%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -13.88%, with highs and lows ranging from $100.00 to […]


Source:US Post News
Inari Medical has best day in over a year as shares climb as much as 14% at one point
Aug 31, 2022 20:19pm

Although shares closed up 5%, Inari Medical (NARI) at one point Wednesday afternoon was up ~14%, its biggest one-day gain since March 2021.


Source:Seeking Alpha
Can you now get a good deal on Inari Medical Inc.’s shares?
Aug 31, 2022 11:16am

Inari Medical Inc. (NASDAQ:NARI) closed Tuesday at $65.95 per share, down from $66.80 a day earlier. While Inari Medical Inc. has underperformed by -1.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -18.90%, with highs and lows ranging from $100.00 to $50.50, whereas […]


Source:US Post News
Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever System in Deep Vein Thrombosis
Aug 30, 2022 20:01pm

IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the DEFIANCE trial. DEFIANCE is a randomized controlled trial (“RCT”) comparing the clinical outcomes of patients with iliofemoral deep


Source:Wallstreet:Online
Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis
Aug 30, 2022 20:01pm

IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the DEFIANCE trial.


Source:GlobeNewswire
Inari Medical Inc. (NASDAQ: NARI) Could Slash -66.56% Soon
Aug 20, 2022 14:30pm

Inari Medical Inc. (NASDAQ:NARI) price on Friday, August 19, fall -1.51% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $75.05. A look at the stock’s price movement, the close in the last trading session was $76.20, moving within a range at $73.71 and $75.51. The beta value … Inari Medical Inc. (NASDAQ: NARI) Could Slash -66.56% Soon Read More »


Source:Stocks Register